Hruby and Mac Hadley (University of Arizona, USA) in 19871989 Original development program Competitive Technologies Palatin Technologies , later spun off into PT-141 (bremelanotide) Target: non-selective agonist of MC1R, MC3R, MC4R, MC5R (more potent than -MSH, longer half-life) Standard experimental dose in human tanning studies: 0.025 mg/kg subcutaneously (Dorr 1996) In Dorr 1996 (n=10): increase in skin melanin density measured by colorimetry by ~25 % after a 10-day course Main adverse effects in the preclinical literature: nausea, flushing, hyperpigmentation (including atypical nevi), priapism Approximately 100+ publications in PubMed
Strengthen your bodys natural defenses with Thymosin Alpha-1 therapy
PLoS One, 13 ,
At South Vibe Finishes, we believe in clear communication and transparency from the very beginning
See also immune system boost with IV therapy
The finding that GLP-1 receptor agonists may be associated with a modest reduction in incident depression compared to DPP-4 inhibitors suggests that these agents could offer dual benefits providing effective glycemic control while also contributing to mood stabilization